Acknowledgement
Supported by : National Nutrition and Food Technology Research Institute of Iran
References
-
Clark BC, Manini TM. Sarcopenia
$\neq$ dynapenia. J Gerontol A Biol Sci Med Sci 63:829-834, 2008 https://doi.org/10.1093/gerona/63.8.829 - Clark BC, Manini TM. What is dynapenia? Nutrition 28: 495-503, 2012 https://doi.org/10.1016/j.nut.2011.12.002
- Fahal IH. Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant 29:1655-1665, 2014 https://doi.org/10.1093/ndt/gft070
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412-423, 2010 https://doi.org/10.1093/ageing/afq034
- Kato A, Ishida J, Endo Y, et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 26:1967-1976, 2011 https://doi.org/10.1093/ndt/gfq652
- Lawman HG, Troiano RP, Perna FM, Wang CY, Fryar CD, Ogden CL. Associations of relative handgrip strength and cardiovascular disease biomarkers in U.S. adults, 2011-2012. Am J Prev Med 50:677-683, 2016 https://doi.org/10.1016/j.amepre.2015.10.022
- Park J, Ahmadi SF, Streja E, et al. Obesity paradox in endstage kidney disease patients. Prog Cardiovasc Dis 56:415-425, 2014 https://doi.org/10.1016/j.pcad.2013.10.005
- Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793-808, 2003 https://doi.org/10.1046/j.1523-1755.2003.00803.x
- Malhotra R, Deger SM, Salat H, et al. Sarcopenic obesity definitions by body composition and mortality in the hemodialysis patients. J Ren Nutr 27:84-90, 2017 https://doi.org/10.1053/j.jrn.2016.09.010
- Androga L, Sharma D, Amodu A, Abramowitz MK. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int Rep 2:201-211, 2017 https://doi.org/10.1016/j.ekir.2016.10.008
- Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 13:460-466, 2009 https://doi.org/10.1007/s12603-009-0084-z
- Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 62:253-260, 2014 https://doi.org/10.1111/jgs.12652
- Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci 30:264-271, 2015 https://doi.org/10.3346/jkms.2015.30.3.264
- Senechal M, Dionne IJ, Brochu M. Dynapenic abdominal obesity and metabolic risk factors in adults 50 years of age and older. J Aging Health 24:812-826, 2012 https://doi.org/10.1177/0898264312440324
- Rossi AP, Fantin F, Caliari C, et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: a 10-year prospective study. Clin Nutr 35:199-204, 2016 https://doi.org/10.1016/j.clnu.2015.02.005
- Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30:1718-1725, 2015 https://doi.org/10.1093/ndt/gfv133
- Ren H, Gong D, Jia F, Xu B, Liu Z. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail 38:364-371, 2016 https://doi.org/10.3109/0886022X.2015.1132173
- Hashemi R, Heshmat R, Motlagh AD, et al. Sarcopenia and its determinants among Iranian elderly (SARIR): study protocol. J Diabetes Metab Disord 11:23, 2012 https://doi.org/10.1186/2251-6581-11-23
- Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15:95-101, 2014 https://doi.org/10.1016/j.jamda.2013.11.025
- Gracia-Iguacel C, Qureshi AR, Avesani CM, et al. Subclinical versus overt obesity in dialysis patients: more than meets the eye. Nephrol Dial Transplant 28 Suppl 4:iv175-iv181, 2013 https://doi.org/10.1093/ndt/gft113
- Tabibi H, Imani H, Hedayati M, Atabak S, Rahmani L. Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients: a randomized controlled trial. Perit Dial Int 30:611-618, 2010 https://doi.org/10.3747/pdi.2009.00161
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
- Imani H, Tabibi H, Atabak S, et al. Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients. J Ren Nutr 19:389-395, 2009 https://doi.org/10.1053/j.jrn.2009.01.020
- Oreopoulos DG, Rao PS. Assessing peritoneal ultrafiltration, solute transport, and volume status. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis, 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 361-372, 2001
- Scott D, Sanders KM, Aitken D, Hayes A, Ebeling PR, Jones G. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity (Silver Spring) 22:1568-1574, 2014 https://doi.org/10.1002/oby.20734
- Tabibi H, As'habi A, Heshmati BN, Mahdavi-Mazdeh M, Hedayati M. Prevalence of protein-energy wasting and its various types in Iranian hemodialysis patients: a new classification. Ren Fail 34:1200-1205, 2012 https://doi.org/10.3109/0886022X.2012.718710
- Cho Y, Hawley CM, Johnson DW. Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol 2014:909373, 2014
- Tedgui A. The role of inflammation in atherothrombosis: implications for clinical practice. Vasc Med 10:45-53, 2005 https://doi.org/10.1191/1358863x05vm589ra
- Iantorno M, Campia U, Di Daniele N, et al. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents 28:169-176, 2014
- Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272-1280, 2003 https://doi.org/10.1093/ndt/gfg074
- Wanner C. Altered lipid metabolism and serum lipids in renal disease and renal failure. In: Kopple JD, Massary SG, eds. Kopple and Massry's Nutritional Management of Renal Disease, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 42-55, 2004
- Lacour B, Massy Z, Drueke TB. Lipid metabolism. In: Massry SG, Glassock RJ, eds. Massry & Glassock's Textbook of Nephrology, 4th edition. Philadelphia: Williams & Wilkins, 1346-1356, 2001
- Prichard SS. Metabolic complications of peritoneal dialysis. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis, 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 405-410, 2001
- Lysine LK, Israel DA. Nutrition in weight management. In: Mahan LK, Escott-Stump S, Raymond J, eds. Krause's Food and the Nutrition Care Process, 13th edition. Missouri: Saunders, 462-487, 2012
- Cannon JG. Cytokines and eicosanoids. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, eds. Modern Nutrition in Health and Disease, 10th edition. Philadelphia: Lippincott Williams & Wilkins, 663, 2006
- Nishimura F, Taniguchi A, Yamaguchi-Morimoto M, et al. Periodontal infection and dyslipidemia in type 2 diabetics: association with increased HMG-CoA reductase expression. Horm Metab Res 38:530-535, 2006 https://doi.org/10.1055/s-2006-949525
- Feingold KR, Spady DK, Pollock AS, Moser AH, Grunfeld C. Endotoxin, TNF, and IL-1 decrease cholesterol 7 alphahydroxylase mRNA levels and activity. J Lipid Res 37:223-228, 1996
- Vaziri ND. Altered lipid metabolism and serum lipids in kidney disease and kidney failure. In: Kopple JD, Massry SG, Kalantar-zadeh K, eds. Nutritional Management of Renal Disease, 3rd edition. Amsterdam: Academic Press, 31-48, 2013
- Cheung AK. Is lipid control necessary in hemodialysis patients? Clin J Am Soc Nephrol 4 Suppl 1:S95-S101, 2009 https://doi.org/10.2215/CJN.04780709
Cited by
- Sarcopenia disease in Iran: an overview vol.18, pp.2, 2018, https://doi.org/10.1007/s40200-019-00452-9
- Non-Systematic Review of Diet and Nutritional Risk Factors of Cardiovascular Disease in Obesity vol.12, pp.3, 2020, https://doi.org/10.3390/nu12030814
- Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single centre in Turkey vol.44, pp.2, 2020, https://doi.org/10.3906/sag-1909-98
- PHYSICAL ACTIVITY AND CARDIORESPIRATORY FITNESS ATTENUATE THE IMPACT OF SARCOPENIC-OBESITY ON CARDIOVASCULAR DISEASE RISK IN KOREAN MEN: A CROSS SECTIONAL STUDY vol.16, pp.2, 2018, https://doi.org/10.15586/jomh.v16i2.251
- Physical performance and chronic kidney disease development in elderly adults: results from a nationwide cohort study vol.12, pp.17, 2018, https://doi.org/10.18632/aging.103741
- The Effect of Exercise on Nutritional Status and Body Composition in Hemodialysis: A Systematic Review vol.12, pp.10, 2018, https://doi.org/10.3390/nu12103071
- The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications vol.22, pp.9, 2018, https://doi.org/10.3390/ijms22094339
- Sarcopenia in hemodialysis patients from Buenos Aires, Argentina vol.7, pp.2, 2018, https://doi.org/10.1016/j.afos.2021.04.001
- Significant Association of Diabetes With Mortality of Chronic Hemodialysis Patients, Independent of the Presence of Obesity, Sarcopenia, and Sarcopenic Obesity vol.32, pp.1, 2022, https://doi.org/10.1053/j.jrn.2021.07.003